• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病微血管并发症的决定因素与分层

Determinants and Stratification of Microvascular Complications of Type 2 Diabetes Mellitus.

作者信息

Reddy Mallimala Priya, Shah Kavita, Mirchandani Mohit, Sharma Karan

机构信息

Medicine, Kurnool Medical College, Bangalore, IND.

Medicine, North Carolina Medical Center, Benson, USA.

出版信息

Cureus. 2023 Aug 29;15(8):e44348. doi: 10.7759/cureus.44348. eCollection 2023 Aug.

DOI:10.7759/cureus.44348
PMID:37779807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10539158/
Abstract

Background Diabetes mellitus (DM) is a prevalent metabolic disorder characterized by high blood sugar levels. It is classified into type 1 (T1DM) and type 2 (T2DM), which have different mechanisms and complications. The global prevalence of diabetes, particularly T2DM, has increased significantly in recent decades, leading to a need for standardized data collection of macrovascular and microvascular complications to track disease progression and guide treatment options. This study aims to assess and correlate the prevalence and severity of microvascular complications in patients with T2DM. Methodology This observational, cross-sectional study was conducted at Poonam Multispeciality Hospital in Ahmedabad, India. A total of 4,123 diabetic patients admitted to the hospital were included. Information on sociodemographics and medical history was collected using standardized forms. Fundus photography and fluorescein angiography were performed to assess diabetic retinopathy, and estimated glomerular filtration rate and albumin-to-creatinine ratio were measured to evaluate renal function. Neurological examinations were conducted to score diabetic neuropathy. Chi-square tests were used to determine associations between medical history with diabetic retinopathy and nephropathy, and t-tests were used to compare diabetic neuropathy scores. Kendall's Tau correlation was used to determine correlations between diabetic retinopathy and nephropathy. P-values <0.05 were considered statistically significant. Results The overall prevalence of diabetic retinopathy, nephropathy, and neuropathy was 37.5%. Of the patients included, 47.9% had diabetic nephropathy and 28.9% had diabetic neuropathy. A significant association was observed between the severity of diabetic retinopathy and age, body mass index, duration of diabetes, and hemoglobin A1c (HbA1C) levels. Similarly, significant associations were found between these factors and the severity of diabetic nephropathy. Unpaired t-tests revealed significant differences in diabetic neuropathy examination scores based on the duration of diabetes and Hba1C levels. Moreover, correlation analysis indicated a low, positive correlation between diabetic retinopathy and diabetic nephropathy. Conclusions This study provides insights into the prevalence, severity, and associations of microvascular complications in patients with T2DM, contributing to the understanding and management of these conditions. Additionally, the research revealed a direct association between diabetic retinopathy and different stages of chronic kidney disease determined by the Kidney Disease Improving Global Outcome guidelines.

摘要

背景 糖尿病(DM)是一种以高血糖水平为特征的常见代谢紊乱疾病。它分为1型糖尿病(T1DM)和2型糖尿病(T2DM),两者机制和并发症不同。近几十年来,全球糖尿病患病率显著上升,尤其是T2DM,这就需要对大血管和微血管并发症进行标准化数据收集,以追踪疾病进展并指导治疗方案。本研究旨在评估和关联T2DM患者微血管并发症的患病率和严重程度。

方法 本观察性横断面研究在印度艾哈迈达巴德的普纳姆多专科医院进行。共纳入4123名住院糖尿病患者。使用标准化表格收集社会人口统计学和病史信息。进行眼底摄影和荧光素血管造影以评估糖尿病视网膜病变,测量估算肾小球滤过率和白蛋白与肌酐比值以评估肾功能。进行神经学检查以对糖尿病神经病变进行评分。采用卡方检验确定病史与糖尿病视网膜病变和肾病之间的关联,采用t检验比较糖尿病神经病变评分。采用肯德尔 Tau 相关性分析确定糖尿病视网膜病变和肾病之间的相关性。P值<0.05被认为具有统计学意义。

结果 糖尿病视网膜病变、肾病和神经病变的总体患病率为37.5%。纳入的患者中,47.9%患有糖尿病肾病,28.9%患有糖尿病神经病变。观察到糖尿病视网膜病变的严重程度与年龄、体重指数、糖尿病病程和糖化血红蛋白(HbA1C)水平之间存在显著关联。同样,在这些因素与糖尿病肾病的严重程度之间也发现了显著关联。非配对t检验显示,根据糖尿病病程和糖化血红蛋白水平,糖尿病神经病变检查评分存在显著差异。此外,相关性分析表明糖尿病视网膜病变与糖尿病肾病之间存在低度正相关。

结论 本研究深入了解了T2DM患者微血管并发症的患病率、严重程度及关联,有助于对这些疾病的理解和管理。此外,该研究揭示了糖尿病视网膜病变与由改善全球肾脏病预后组织指南确定的慢性肾脏病不同阶段之间的直接关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb81/10539158/5aa9f03e51b2/cureus-0015-00000044348-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb81/10539158/55cd7c344bb6/cureus-0015-00000044348-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb81/10539158/da9ebbd3cdae/cureus-0015-00000044348-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb81/10539158/4131dfa97f29/cureus-0015-00000044348-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb81/10539158/5aa9f03e51b2/cureus-0015-00000044348-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb81/10539158/55cd7c344bb6/cureus-0015-00000044348-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb81/10539158/da9ebbd3cdae/cureus-0015-00000044348-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb81/10539158/4131dfa97f29/cureus-0015-00000044348-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb81/10539158/5aa9f03e51b2/cureus-0015-00000044348-i04.jpg

相似文献

1
Determinants and Stratification of Microvascular Complications of Type 2 Diabetes Mellitus.2型糖尿病微血管并发症的决定因素与分层
Cureus. 2023 Aug 29;15(8):e44348. doi: 10.7759/cureus.44348. eCollection 2023 Aug.
2
Prevalence of Metabolic Syndrome and Its Risk Factors Influence on Microvascular Complications in Patients With Type 1 and Type 2 Diabetes Mellitus.1型和2型糖尿病患者代谢综合征的患病率及其危险因素对微血管并发症的影响
Cureus. 2024 Mar 4;16(3):e55478. doi: 10.7759/cureus.55478. eCollection 2024 Mar.
3
Association Between Estimated Glomerular Filtration Rate and Microvascular Complications in Type II Diabetes Mellitus Patients: A 1-Year Cross-Sectional Study.估算肾小球滤过率与 2 型糖尿病患者微血管并发症的关系:一项为期 1 年的横断面研究。
J Natl Med Assoc. 2019 Feb;111(1):83-87. doi: 10.1016/j.jnma.2018.06.003. Epub 2018 Jul 20.
4
Metabolic Syndrome in Type 2 Diabetes Mellitus Patients: Prevalence, Risk Factors, and Associated Microvascular Complications.2型糖尿病患者的代谢综合征:患病率、危险因素及相关微血管并发症
Cureus. 2023 May 16;15(5):e39076. doi: 10.7759/cureus.39076. eCollection 2023 May.
5
Microalbuminuria as the Tip of Iceberg in Type 2 Diabetes Mellitus: Prevalence, Risk Factors, and Associated Diabetic Complications.微量白蛋白尿:2型糖尿病的冰山一角——患病率、危险因素及相关糖尿病并发症
Cureus. 2023 Aug 9;15(8):e43190. doi: 10.7759/cureus.43190. eCollection 2023 Aug.
6
Diagnosing type 2 diabetes using Hemoglobin A1c: a systematic review and meta-analysis of the diagnostic cutpoint based on microvascular complications.使用糖化血红蛋白诊断 2 型糖尿病:基于微血管并发症的诊断切点的系统评价和荟萃分析。
Acta Diabetol. 2021 Mar;58(3):279-300. doi: 10.1007/s00592-020-01606-5. Epub 2020 Nov 3.
7
Evaluation of microvascular complications in patients with new diagnosis type 2 diabetes.新诊断2型糖尿病患者微血管并发症的评估
Eur Rev Med Pharmacol Sci. 2023 Feb;27(4):1601-1608. doi: 10.26355/eurrev_202302_31403.
8
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.1型糖尿病强化血糖控制与传统血糖控制的比较
Cochrane Database Syst Rev. 2014 Feb 14;2014(2):CD009122. doi: 10.1002/14651858.CD009122.pub2.
9
Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.早发型 2 型糖尿病的临床特征及微血管并发症危险因素。
Curr Med Sci. 2019 Oct;39(5):754-758. doi: 10.1007/s11596-019-2102-7. Epub 2019 Oct 14.
10
Clinical correlation of diabetic retinopathy with nephropathy and neuropathy.糖尿病视网膜病变与肾病和神经病变的临床关联
Indian J Ophthalmol. 2021 Nov;69(11):3364-3368. doi: 10.4103/ijo.IJO_1237_21.

引用本文的文献

1
The efficacy of saffron supplementation on inflammation and oxidative stress in patients with type-2 diabetes mellitus: a meta-analysis.藏红花补充剂对2型糖尿病患者炎症和氧化应激的疗效:一项荟萃分析。
Front Endocrinol (Lausanne). 2025 Aug 6;16:1634982. doi: 10.3389/fendo.2025.1634982. eCollection 2025.

本文引用的文献

1
Global trends in diabetes complications: a review of current evidence.全球糖尿病并发症趋势:现有证据综述。
Diabetologia. 2019 Jan;62(1):3-16. doi: 10.1007/s00125-018-4711-2. Epub 2018 Aug 31.
2
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.国际糖尿病联盟糖尿病地图:2015年和2040年全球糖尿病患病率估计
Diabetes Res Clin Pract. 2017 Jun;128:40-50. doi: 10.1016/j.diabres.2017.03.024. Epub 2017 Mar 31.
3
Diabetic retinopathy and the associated risk factors in diabetes type 2 patients in Abha, Saudi Arabia.
沙特阿拉伯阿卜哈地区2型糖尿病患者的糖尿病视网膜病变及相关危险因素。
J Family Community Med. 2016 Jan-Apr;23(1):18-24. doi: 10.4103/2230-8229.172225.
4
Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015.糖尿病神经病变的风险因素与共病:2015年更新
Rev Diabet Stud. 2015 Spring-Summer;12(1-2):48-62. doi: 10.1900/RDS.2015.12.48. Epub 2015 Aug 10.
5
Prevalence of micro and macrovascular complications and their risk factors in type-2 diabetes mellitus.2型糖尿病微血管和大血管并发症的患病率及其危险因素
J Assoc Physicians India. 2014 Jun;62(6):504-8.
6
Prevalence and risk factors for diabetic retinopathy in rural India. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study III (SN-DREAMS III), report no 2.印度农村糖尿病视网膜病变的患病率及危险因素。Sankara Nethralaya 糖尿病视网膜病变流行病学和分子遗传学研究 III(SN-DREAMS III)报告第 2 号。
BMJ Open Diabetes Res Care. 2014 Jun 6;2(1):e000005. doi: 10.1136/bmjdrc-2013-000005. eCollection 2014.
7
Link between retinopathy and nephropathy caused by complications of diabetes mellitus type 2.2型糖尿病并发症所致视网膜病变与肾病之间的关联
Int Ophthalmol. 2015 Feb;35(1):59-66. doi: 10.1007/s10792-014-0018-6. Epub 2014 Nov 13.
8
Mechanism of diabetic neuropathy: Where are we now and where to go?糖尿病神经病变的机制:我们目前的状况及未来方向?
J Diabetes Investig. 2011 Jan 24;2(1):18-32. doi: 10.1111/j.2040-1124.2010.00070.x.
9
The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution.改善全球肾脏病预后组织(KDIGO)慢性肾脏病指南更新:循序渐进,而非彻底变革。
Clin Chem. 2013 Mar;59(3):462-5. doi: 10.1373/clinchem.2012.184259.
10
Diabetic retinopathy.糖尿病视网膜病变
N Engl J Med. 2012 Mar 29;366(13):1227-39. doi: 10.1056/NEJMra1005073.